These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6245467)

  • 1. [Fenfluramine and its effects on the sympathetic nervous system in man (author's transl)].
    Lake CR; Coleman MD; Ziegler MG; Murphy DL
    Sem Hop; 1980 Mar 18-25; 56(11-12):595-600. PubMed ID: 6245467
    [No Abstract]   [Full Text] [Related]  

  • 2. Fenfluramine lowers plasma norepinephrine in overweight subjects.
    Chernow B; Lake CR; Cook D; Coyle J; Hughes P; Coleman MD; Ziegler MG
    Int J Clin Pharmacol Res; 1983; 3(4):233-7. PubMed ID: 6678821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in plasma norepinephrine during fenfluramine treatment.
    de la Vega CE; Slater S; Ziegler MG; Lake CR; Murphy DL
    Clin Pharmacol Ther; 1977 Feb; 21(2):216-21. PubMed ID: 319936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and long-term effects of beta-adrenergic blockade on blood pressure and sympathetic activity in man [proceedings].
    Benedict CR; Pickering TG; Raine AE
    J Physiol; 1977 Oct; 271(2):35P-36P. PubMed ID: 21959
    [No Abstract]   [Full Text] [Related]  

  • 5. [Does fenfluramine mean a real advance in the treatment of obesity?].
    Chruściel M; Chruściel TL
    Postepy Hig Med Dosw; 1973; 27(3):365-90. PubMed ID: 4198497
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of clonidine on sympathetic nervous system activity in patients with essential hypertension.
    Chernow B; Lake CR; Zaloga GP; Coleman MD; Ziegler MG
    Int J Clin Pharmacol Res; 1983; 3(1):9-15. PubMed ID: 6679510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The sympathetic nervous system and dopamine-beta-hydroxylase in hypertension].
    Karppanen H
    Duodecim; 1977; 93(5):301-3. PubMed ID: 844450
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of obesity with fenfluramine.
    Schindler H; Bielesz G
    Wien Med Wochenschr; 1975 Jan; 125(5):85-8. PubMed ID: 1124579
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacology and biochemistry of fenfluramine].
    Duhault J
    Vie Med Can Fr; 1973; 2(2):141-7. PubMed ID: 4574870
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum dopamine-beta-hydroxylase-activity in acute myocardial infarction (author's transl)].
    Takahashi E; Maekawa S; Honda K; Ozawa M; Kimura T
    Schweiz Rundsch Med Prax; 1978 Jan; 67(2):54-6. PubMed ID: 619351
    [No Abstract]   [Full Text] [Related]  

  • 11. [State of the dopamine system activity, as one of factors for the development of arterial hypertension and obesity].
    Lyzogub VH; Dolynna OV; Bogdan TV; Sobol' VO
    Lik Sprava; 2012; (3-4):41-7. PubMed ID: 23356136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Variation of sympathetic activity and prostaglandin E level under acupuncture anesthesia (author's transl)].
    Zhang XZ; Yu Y; Chou LW; Peng JY; Cui SY; Cheng LY; Chen YZ; Zhou S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Dec; 2(4):259-62. PubMed ID: 6458377
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlation between physical load, sympathicus activity and prostaglandins of groups A + E and F in healthy individuals (author's transl)].
    Rysánek K; Prikryl P; Kunovská V; Malinovská M; Matĕjková J; Továrek J; Bílková B; Vojtková J
    Cas Lek Cesk; 1978 Sep; 117(36):1113-7. PubMed ID: 213194
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Serum dopamine-beta-hydroxylase (regulation of catecholamine-release by various agents).
    Ouchi T; Takenoshita M; Tanaka S
    Jpn J Pharmacol; 1974; 24(0):s:25. PubMed ID: 4545594
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs, appetite and obesity: a personal odyssey.
    Silverstone T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 2():S49-52. PubMed ID: 1335991
    [No Abstract]   [Full Text] [Related]  

  • 16. Fenfluramine in the management of obesity.
    Datey KK; Kelkar PN; Pandya RS
    Br J Clin Pract; 1973 Oct; 27(10):373-5. PubMed ID: 4601613
    [No Abstract]   [Full Text] [Related]  

  • 17. The anorectic and hypotensive effect of fenfluramine in obesity.
    Hudson KD
    J R Coll Gen Pract; 1977 Aug; 27(181):497-501. PubMed ID: 616838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: The role of dopamine-beta-hydroxylase as an indicator of the sympathetic nerve tonus.
    Rysánek K; Kuhn E; Spánková H; Továrek J; Voznícek J
    Act Nerv Super (Praha); 1975; 17(4):256-7. PubMed ID: 1221786
    [No Abstract]   [Full Text] [Related]  

  • 19. Release of dopamine beta-hydroxylase during sympathetic nervous activity in tetraplegic man.
    Frankel HL; Mathias CJ; Smith AD; Spalding JM
    J Physiol; 1975 May; 247(1):38P-40P. PubMed ID: 1138066
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Serum dopamine-beta-hydroxylase: a possible aid in the evaluation of hypertension.
    Schanberg SM; Stone RA; Kirshner N
    Psychopharmacol Bull; 1974 Jul; 10(3):27-8. PubMed ID: 4419441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.